On May 2, 2023, BIOGENERA’s shareholders’ meeting approved the 2022 budget; the new Board of Directors (BOD) was also appointed on this occasion. Dr. Thibaud Eckenschwiller has been appointed chairman of the board of BIOGENERA. Dr. Eckenschwiller is a top manager in the pharmaceutical industry with extensive international experience. Dr. Eckenschwiller is Senior Life Sciences C-suite Executive globally, with extensive experience in organizing and managing Big Pharma and Specialty Care Pharma Companies. He has served as CFO or CEO in Novartis, Ypsen, Zambon and Medichem.
Thibaud Eckenschwiller has been appointed president of BIOGENERA, May 2023
